Targeted nanoparticles for imaging and therapy of endometriosis
Biology of Reproduction · 12.06.2024 · 110 (6) · 1191-1200
DOI: 10.1093/biolre/ioae073 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biology of Reproduction, online erschienen am 13.05.2024. Verfasst von Ov Slayden und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA. Hauptthemen laut MEDLINE: Endometriosis, Nanoparticles. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, NICHD NIH HHS, NIH.
Abstract (Originalsprache)
In this brief review, we discuss our efforts to validate nanoplatforms for imaging and treatment of endometriosis. We specifically highlight our use of nonhuman primates and primate tissues in this effort. Endometriosis is a painful disorder of women and nonhuman primates where endometrium-like tissue exists outside of the uterus. There are no reliable, specific, and noninvasive diagnostic tests for endometriosis. Laparoscopic imaging remains the gold standard for identifying small endometriotic lesions in both women and monkeys. Visualizing and surgically removing microscopic lesions remains a clinical challenge. To address this challenge, we have created nanoparticle reagents that, when administered intravenously, enter endometriotic lesions both passively and by targeting endometriotic cells. The particles can carry payloads, including near-infrared fluorescent dyes and magnetic nanoparticles. These agents can be used for imaging and thermal ablation of diseased tissues. We evaluated this approach on macaque endometriotic cells, human and macaque endometrium engrafted into immunodeficient mice, in endometrium subcutaneously autografted in macaques, and in rhesus monkeys with spontaneous endometriosis. Employing these models, we report that nanoplatform-based reagents can improve imaging and provide thermal ablation of endometriotic tissues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA.
- Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR, USA.
- School of Medicine, Oregon Health & Science University, Portland, OR, USA.
Förderung
- NIH HHS
- NICHD NIH HHS
- NIH
Zitieren
APA
Slayden, O., Luo, F., Park, Y., Moses, A. S., Demessie, A. A., Singh, P., Korzun, T., Taratula, O., & Taratula, O. (2024). Targeted nanoparticles for imaging and therapy of endometriosis. Biology of Reproduction, 110(6), 1191-1200. https://doi.org/10.1093/biolre/ioae073
Vancouver
Slayden O, Luo F, Park Y, Moses AS, Demessie AA, Singh P, et al. Targeted nanoparticles for imaging and therapy of endometriosis. Biology of Reproduction. 2024;110(6):1191-1200. doi:10.1093/biolre/ioae073
BibTeX
@article{Slayden2024,
author = {Slayden, Ov and Luo, Fangzhou and Park, Youngrong and Moses, Abraham S and Demessie, Ananiya A and Singh, Prem and Korzun, Tetiana and Taratula, Olena and Taratula, Oleh},
title = {Targeted nanoparticles for imaging and therapy of endometriosis},
journal = {Biology of Reproduction},
year = {2024},
volume = {110},
number = {6},
pages = {1191--1200},
doi = {10.1093/biolre/ioae073}
}
EUVIMED